How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that specialty drug classification creates both barriers and opportunities for patients seeking GLP-1 therapy
For patients seeking additional weight loss, microdosing is generally less effective than standard therapeutic dosing
Getting a branded GLP-1 covered by insurance is genuinely painful for many patients
GHK-Cu is studied in laboratory research environments across multiple categories including copper peptide research, skin and tissue research, collagen pathway studies, wound research models, antioxidant pathway research, hair follicle research and ageing biology
Alternative injection sites like the thigh or abdomen can be rotated systematically
What GLP-1 medications actually do to your hydration GLP-1 receptor agonists work by slowing gastric emptying, reducing appetite and regulating blood sugar